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Abstract
Background: Genomic imbalances of the 12q telomere are rare; only a few patients having 12q24.31-q24.33
deletions were reported. Interestingly none of these were mosaic. Although some attempts have been made to
establish phenotype/genotype interaction for the deletions in this region, no clear relationship has been
established to date.
Results: We have clinically screened more than 100 patients with dysmorphic features, mental retardation and
normal karyotype using high density oligo array-CGH (aCGH) and identified a ~9.2 Mb hemizygous interstitial
deletion at the 12q telomere (Chromosome 12: 46,XY,del(12)(q24.31q24.33) in a severely developmentally retarded
patient having dysmorphic features such as low set ears, microcephaly, undescended testicles, bent elbow,
kyphoscoliosis, and micropenis. Parents were found to be not carriers. MLPA experiments confirmed the aCGH
result. Interphase FISH revealed mosaicism in cultured peripheral blood lymphocytes.
Conclusions: Since conventional G-Banding technique missed the abnormality; this work re-confirms that any child
with unexplained developmental delay and systemic involvement should be studied by aCGH techniques. The FISH
technique, however, would still be useful to further delineate the research work and identify such rare mosaicism.
Among the 52 deleted genes, P2RX2, ULK1, FZD10, RAN, NCOR2 STX2, TESC, FBXW8, and TBX3 are noteworthy since
they may have a role in observed phenotype.
Background
Genomic imbalances certainly are major causes of con-
genital and developmental abnormalities. These include
dysmorphia, mental retardation, developmental delay,
and multiple congenital anomalies. Some of these
genetic anomalies causing such phenotypes can be var-
ious and some of these are associated to telomeric/
subtelomeric deletions. Among these chromosome
12q24.31-q24.33 telomeric/subtelomeric deletions are
rare and only a few patients have been reported pre-
viously [1-3]; interestingly none of these were mosaic.
Some attempts were made to establish phenotype-
genotype correlation [1], no clear relationship could be
found. Genes such as RAN, P2RX2, FZD10,a n dULK1
were mentioned as likely candidate genes implicated in
the clinical features of the patients reported [1]. In this
report a detailed clinical description and molecular
cytogenetics analysis of a patient with de novo 12q
interstitial deletion is presented. The deleted region
contains 52 annotated genes. Among these P2RX2,
ULK1, FZD10, RAN, NCOR2, STX2, TESC, FBXW8,
and TBX3 are noteworthy. The function of these genes
and some others in 12q24.31-q24.33 region as well as
patients having 12q24 related abnormalities were over-
viewed and discussed to better understand the clinical
phenotype. * Correspondence: nkaya@kfshrc.edu.sa
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Clinical Details of the Patient
The patient (Figure 1A-G), a 10-year-old boy, was born
in 2000. Pregnancy and delivery were normal with no
history of antenatal and perinatal complications. Family
history indicated the parents to be first cousins. They
had four normal sons and two normal daughters. There
were two miscarriages (Figure 2 Panel I A). No chronic
diseases or congenital anomalies exist in the family. The
patient was hospitalized twice with chest infection dur-
ing early infancy. Early global delay of developmental
milestones was present. He sat at 10 months and walked
at two years of age. He spoke only two words.
At 5 9/12 years of age his height, weight and head cir-
cumference were 83 cm, 13 kg and 47.5 cm. These
represented the medians of 19/69, 24/69 and 14/69
respectively; and all were well below 3
rd percentile. He
had micrognathia, small ears, impalpable testes, elbow
deformity and kyphoscoliosis. He had a short and small
penis in addition to the undescended testicles. The sys-
tem examination including chest, heart, abdomen and
central and peripheral nervous system were all normal.
The blood count, renal and hepatic profile and other
chemistries were within normal limits. The ECG was
normal. A karyotyping and FISH examination for
22q11.2 region were normal. The diagnosis of panhypo-
pituitarism was entertained. The IGF1 was 24 mEq/Lv.
T h eT Sa n dT S Hw e r en o r m a l .U pt os e v e ny e a r so f
age, he showed poor speech, developmental delay and
growth retardation; his height was 87 cm, at 2 years
chronological age was 6 years. At present he is 10-year-
old with no improvement in his clinical findings (Figure
1A-G).
Molecular Findings
Standard G-banding performed on patient’sl y m p h o c y t e s
showed no chromosomal abnormality. The Agilent’s
Human Genome CGH Microarray 244A array revealed
that telomere of 12q showed an interstitial hemizygous
deletion starting from the middle of 12q24.31 Mb
(132293878 bp) to the near end of the q arm (123065364
bp) (Chromosome 12: 46,XY,del(12)(q24.31q24.33) on
the patient’s DNA (Figure 2 Panel I B). No other chro-
mosomal imbalances were identified. Parents were also
t e s t e db yt h es a m ea r r a yt y p eb u ty i e l d e dn os u c hd e l e -
tion. The aCGH result was confirmed by MLPA assay
(data not shown). A detailed breakpoint analysis is given
in Additional file 1. Two independent interphase FISH
experiments were performed on cultured peripheral
blood lymphocytes from the patient using commercially
available 12q telomeric and chr12 centromeric FISH
probes from Vysis Inc. Each time 250 cells were counted
at interphase. These results indicated mosacism with
three different cell types a) wild type cells having four sig-
nals two centromeric and two telomeric (44.5%), b)
mutant cells with hemizygous 12q telomeric deletion
(30%), c) mutant cells with homozygous 12q telomeric
deletion in the patient (25.5%) (Figure 2 Panel II A, B, C,
respectively). As a next step we wanted to test other tis-
sue types to see if the mosaicism is restricted to the lym-
phocytes. Unfortunately we were not able to reach to the
family to collect more samples to further analyze the
mosaicism.
Discussion
Chromosome abnormalities involving the telomere of
chromosome 12 are rare. A comprehensive subtelomere
FISH analysis was conducted among 11,688 patients
with developmental disabilities [4]. 357 instances of the
abnormalities were detected such as duplications, dele-
tions, and translocations; out of that 357 only three
patients had chromosome 12q telomere abnormality.
In another study of micro-array based molecular kar-
yotyping as preimplantation genetic screening (PGS)
on 24 h blastomers indicated that 46.2% of 134 blasto-
mers were mosaic euploid. Meiotic trisomies were
negatively predictive of mosaic euploid embryos [5].
The reason for this high frequency of mosaicism at
cleavage stage of development is unknown. One theory
is that mosaicism originates from chromosomally
abnormal oocytes as a result of trisomy rescue [6].
Chromosome mosaicism could also be seen in 1-2% of
chorionic villus biopsies [7]. In their investigation of
15,109 CVS a mosaic condition was found in 203
instances. This was speculated to be either a mitotic
originated event owing to a postzygotic non-dysjunc-
tion resulting a trisomic cell line in an originally nor-
mal conceptus or a meiotic originated event due to
Figure 1 Patient photos. Photos showing the patient and clinical
phenotypes: A) Left arm showing bent elbow, B) Face indicating
long philtrum of upper lip, C) Right arm with bent elbow, D) Facial
features including small ear lobe from left side, E-F) Full body
indicating scoliosis, short stature, micro-retrognathia, respectively.
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mic conceptus namely atrisomy rescue. However, this
placental mosaicism extended only in 12.8% of
instances from placenta into fetal tissues. A study in
mouse indicated that aneuploid embryos could implant
in intrauterine tissue and initiate gastrulation but
quickly degrade and die [8]. Embryo viability due to
chromosomal mosaicism is mediated by p53-indepen-
dent apoptotic mechanism. These observations suggest
that chromosome mosaicism is not uncommon in
pregnancies; although the etiology is unknown it might
be a “rescue mechanism” for a trisomic cell line.
Among mosaic cell lines, abnormality of 12q terminus
should also be rare since in chromosome 12q there is
a local telomere-induced suppression of recombination.
There have been only four instances of deletions
involving 12q24.31-q24.33 region in the literature. The
first instance of such deletions was a female with mild
non-familial mental retardation (MR), but no further
clinical features were reported [3]. The deletion was not
visible by retrospective high-resolution G-banding analy-
sis. Using FISH, the size of the deletion was estimated
to be between 3 and 6 Mb from the telomere. The sec-
ond two instances of 12q subtelomeric deletions were
reported with full clinical description and fine mapping
[1]. Additionally two boys, a 9 months-old, with abnor-
mal genitalia [3] and the other whose interstitial dele-
tion did not include 12q24.33, without abnormal
genitalia were reported [2]. The features of these
patients are listed in Additional file 2 and briefly include
Figure 2 Family pedigree, aCGH data and FISH results. Panel I is presenting the family pedigree and aCGH data analysis results. A.T h e
pedigree indicates presence of two miscarriages, six healthy family members (two girls and four boys) and one affected boy B. aCGH data
showing the largest deletion found on chromosome 12q telomere. The deletion is nearly 9.2 Mb in size and starts from bases of 123097890 and
extends to the near end of the chromosome 12 and therefore, is considered as a novel telomeric deletion. Similar deletions limited to a few
patients were previously reported but the breakpoints and sizes are different. Panel II is depicting three different cells based on interphase FISH
results. A. Interphase FISH showing the wild type cell with four signals (two telomeric red and two centromeric green signals). B. A cell with
hemizygosity indicated by three signals based on the FISH experiments. C. The FISH result depicting only two green signals in a cell indicating
nullisomy for chromosome 12q24.31-q24.33.
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foot abnormalities, obesity, behavioral manifestations, as
food seeking, high tolerance for pain, and various genital
abnormalities [1-3].
The approximate deletion size was 9,228,514bp
(Additional file 1). This deletion is larger than those
that contained 14 and 22 known genes reported before
[1] and comprises at least 52 annotated genes accord-
ing to the NCBI Map Viewer (Build 36.2). The 12q24-
qter region as a block contains more than 300 genes.
Among them 49 are hypothetical genes and another 43
genes are thought to be relevant to the phenotype
(Additional file 3).
In the literature only one report detailed the genes
involved [1]. Their aCGH analysis suggested a possible
role of P2RX2 (purinergic receptor P2X2 isoform 1)
and ULK1 (UNC51-like kinase) genes in patient 1 and
RAS related protein (RAN) and Frizzled 10 (FZD10)i n
the second patient. The main consequences of this
deletion were in the nervous system in both patients
[1]. Since the gene products of both P2RX2 and ULK1
have been demonstrated to be involved in neuronal
function, their haploinsufficiency might be implicated
in MR and behavioral problems that were also
observed in our patient.
Terminal region of chromosome 12 q is involved in
the normal development of male genitalia [3] and most
patients with such deletion had abnormalities of this
organ (Additional file 2). It appears that STX2, TESC
and FBXW8 genes might be responsible for defective
testicular development and TBX3 for small penis.
Another critical gene is NCOR 2 in the region deleted
in the present patient might be involved in the pheno-
type. It has many functions; including its repressive
function through regulation of chromatin [9]. It was
demonstrated NCOR2 is a co-regulator for the androgen
receptor (AR) and through an intricate mechanism
NCOR2 modulates the androgen receptor activity [10].
It is involved in transcriptional regulation by both ago-
nist- and antagonist-bound AR and that it regulates the
magnitude of hormone response [11]. NCOR2 involves
in progression of neural stem cells into neurons by
mediating repression of H3K27 demethylase through
JMJD3 and plays a critical role in forebrain development
and neural stem cell maintenance. It is shown in the
NCOR2 gene-knockout mice that both retinoic-acid-
dependent and Notch-dependent forebrain development
require NCOR2 [12]. These might explain gonadal and
CNS findings in our patient.
In the 12q24 area there are other genes that might be
involved in the phenotype (Additional file 3) including
THRAP2, TBX5 and PTPN11 for cardiac and great ves-
sel anomalies; TBX5, CMKLR1,a n dTRPV4 for skeletal
defects; PRKAB1, GPR109A,a n dGPR109B for increased
hunger and obesity. At least seven genes are closely
related to the function of nervous system: TECT1, MSI1,
DYNLL1, SRRM4, DNAH10, NOS 1, P2RX4 besides
those mentioned before.
Conclusions
In conclusion, it is difficult to speculate for a mosaic
case as to which genes likely to contribute to a clinical
phenotype. This is particularly true for our patient since
only one out of three cells was normal, the other two
were either hemizygous or homozygous for the deletion.
However, generally speaking, based on the function and
annotation of the genes from the literature one can
speculate that P2RX2, ULK1, RAN, FZD10, NCOR2,
STX2, TESC, FBXW8, TBX3, and other 15 genes are
likely to be responsible for the phenotype to a certain
extent.
Methods
Patients, Sample Collection, Cell Culture and DNA
Isolation
After clinical evaluation including dysmorphology exam-
ination, patients and some of their relatives were
recruited under the KFSHRC IRB-approved protocol
(RAC# 2040042 and 2060035) and consented for their
participation to the study. The blood samples were col-
lected into different tubes for DNA, RNA isolation and
cell culture. Nucleic acids isolations and cell culture
were according to standard protocols [13].
Array CGH Experiment
Human Genome CGH Microarray Kit 244A (Agilent
Technologies, Santa Clara, CA, USA) was used in the
aCGH experiments. Genomic DNA preparation, label-
ing, hybridization, scanning, image extraction, data gen-
eration, and visualization were all performed according
to the manufacturer’s instructions (Agilent Inc.).
Cytogenetics Analysis and Interphase FISH Experiment
Chromosome analysis performed on cultured peripheral
blood lymphocytes, using standard G banding techni-
ques. Interphase FISH analysis was performed using two
commercially available probes from Vysis (A centro-
meric probe for Chromosome 12, Vysis CEP12-D12Z3),
and a telomeric probe, Vysis Telysion 12-VIJyRM2196-
LOCUS) on cultured cells according to standard
procedures.
MLPA Assay
SALSA MLPA kit P286 Telomere-11 (MRC-Holland,
Amsterdam, Holland) was used for MLPA experiments.
Experimental procedures and data analysis were per-
formed according to manufacturer’sp r o t o c o l sa n d
guidelines.
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Consent forms for the project and photos were taken
from the parents according to our institution’sI R B
approval.
Additional material
Additional file 1: A detailed proximal and distal breakpoint analysis.
Additional file 2: Clinical summary of cytogenetic abnormalities
involving deletion, duplication, or translocation of 12q telomere.
Additional file 3: Chromosome 12q24-qter genes relevant to
phenotype.
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